Bertrand Loy is a director of Harvard Bioscience Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | ENTG Entegris | Common Stock | Grant | Acquire A | No | No | 0 | 38,208 | 0.00 | 263,068 |
1 Apr 24 | ENTG Entegris | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 140.62 | 65,880 | 9.26 mm | 65,880 |
15 Aug 23 | ENTG Entegris | Common Stock | Payment of exercise | Dispose F | No | No | 95.87 | 9,357 | 897.06 k | 229,189 |
22 May 23 | HBIO Harvard Bioscience | Common Stock | Grant | Acquire A | No | No | 0 | 31,516 | 0.00 | 79,009 |
17 Feb 23 | ENTG Entegris | Common Stock | Payment of exercise | Dispose F | No | No | 85.48 | 14,126 | 1.21 mm | 238,546 |
13 Feb 23 | ENTG Entegris | Common Stock | Payment of exercise | Dispose F | No | No | 84.94 | 8,727 | 741.27 k | 252,672 |
13 Feb 23 | ENTG Entegris | Common Stock | Grant | Acquire A | No | No | 0 | 19,676 | 0.00 | 261,399 |